Shanghai Securities released a research report on January 28, saying that it gave Youcare Pharmaceutical Group Co.Ltd(688658) (688658. SH) a buy rating for the first time. The reasons for rating mainly include: 1) the company aims to focus on R & D and innovation and build a high-end chemical medicine leader integrating API and preparation; 2) Innovative platform pharmaceutical enterprises are emerging, with rich R & D pipelines, and comprehensively start a new journey of innovative drugs; 3) The three heavyweight products provide growth momentum, and traditional products benefit from centralized purchase. Risk warning: risk of new drug research and development; Drug quality risk; Sales channel risk, etc.
© China Stock Market News